Pilot or pivotal ? [General Sta­tis­tics]

posted by Ohlbe – France, 2018-06-27 13:43 (882 d 06:05 ago) – Posting: # 18981
Views: 8,676

Hi ElMaestro,

» This is purely hypothetical for me. As far as I recall, I have not ever faced such a situation where two test formulations targeting the same authority were heads-on compared in a pivotal trial. I have faced it numerous times in pilot trials, but here the choice of formulation rarely is based on the CI but just on the observed GMR.

Precisely. But then, isn't this whole discussion on alpha correction purely hypothetical too ?

Sorry if I'm spoiling a nice thread...

Regards
Ohlbe

Complete thread:

Activity
 Admin contact
21,210 posts in 4,426 threads, 1,481 registered users;
online 13 (1 registered, 12 guests [including 10 identified bots]).
Forum time: Wednesday 19:49 UTC (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5